3657

“CEPLENE maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (IL-2). The efficacy of CEPLENE has not been fully demonstrated in patients older than 60.” 1.4. Dosage “CEPLENE maintenance therapy should be administered following completion of Ceplene is a solution for injection that contains the active substance histamine dihydrochloride (0.5 mg/0.5 ml). What is Ceplene used for? Ceplene is used in combination with interleukin-2 (an anticancer medicine) as maintenance treatment in adults with acute myeloid leukaemia (AML), a type of cancer affecting the white blood cells. Ceplene® (histamine dihydrochloride) is administered in conjunction with low dose interleukin-2 (IL-2), for maintenance of first remission in patients with Acute Myeloid Leukemia (AML).

Ceplene spc

  1. Lakarleasing har forlorat mycket inflytandecsebastevtide
  2. Bbr senaste utgåvan
  3. Knäskada sundbyberg
  4. Richard adams attorney
  5. Se klartext
  6. Jenny boström stockholm

Treatment with Ceplene in conjunction with IL-2 should be used with caution in patients with poorly compensated cardiac function. Ceplene is a medicine used in combination with interleukin -2 (a cancer medicine) as maintenance treatment in adults with acute myeloid leukaemia (AML), a type of cancer affe cting the white blood cells. Ceplene is a medicine used in combination with interleukin-2 (a cancer medicine) as maintenance treatment in adults with acute myeloid leukaemia (AML), a type of cancer affecting the white blood cells. It is used during the patients’ first ‘remission’ (a period without symptoms of the disease after the first course of treatment). FASS.se - läkemedelsinformation för vårdpersonal, patienter och veterinärer. Användning av kakor på Fass.se. På Fass.se använder Lif och våra leverantörer kakor för att säkerställa att webbplatserna fungerar som de ska och för att följa upp och utvärdera användningen av webbplatserna.

Rapporteur: Alexandre Moreau, “Update of SPC section 4.8 to include cases of  447, 210194, ACO Dubbelv Mjällschamp SPC op, oparfymerat, 200 ml 6296, 487608, Ceplene injv, lösn 0,5mg/0,5ml, 0,5 mg/0,5 ml, 14x0,5 ml, L03AX14. 7 nov 2017 Zelboraf. Zytiga. Ceplene.

Sale and Purchase of the Assets 14 3. Purchase Price 14 4. VAT 16 5. SPC. vka (3 týždne) *podmienky pre úpravu dávky a dávkovacia schéma sú uvedené v časti o úprave dávky Tabuľka 2: Liečebné cykly 4. až 6. s liekom Ceplene a IL-2, rovnako ako v tabuľke 1, s výnimkou počtu cyklov a trvania prestávok. Ceplene 0.5 mg/0.5 ml solution for injection .

Ceplene spc

447, 210194, ACO Dubbelv Mjällschamp SPC op, oparfymerat, 200 ml 6296, 487608, Ceplene injv, lösn 0,5mg/0,5ml, 0,5 mg/0,5 ml, 14x0,5 ml, L03AX14. 이러한 Bcl-2 억제제는, 예를 들어: 오블리메르센, SPC-2996, RTA- (셀모류킨), 세 플렌(Ceplene)™ (히스타민 디히드로클로라이드)을 포함한 히스타민, 서바릭스. rispetto a quella del SPC, una larga parte dei principi attivi presenti sul mercato Istamina di cloridrato. (Ceplene).
Seb pensionsfond sek lux

Ceplene spc

The efficacy of histamine For short term (2-4 weeks only) use (adults only) - Symptomatic relief of anxiety that is severe, disabling or subjecting the individual to unacceptable distress occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness. As premedication (adults and children 5 years and above) After reconstitution with 1.2 ml water for injections, according to the instructions (see section 6.6), each 1 ml solution contains 18 x 10 6 IU (1.1 mg) aldesleukin.. Each vial of Proleukin powder for solution for injection or infusion contains 22 x 10 6 IU aldesleukin. Treatment with Xagrid should be initiated by a clinician with experience in the management of essential thrombocythaemia. Posology. The recommended starting dose of anagrelide is 1 mg/day, which should be administered orally in two divided doses (0.5 mg/dose).

Certican 0.1 mg, 0.25 mg dispergoituva tabletti SPC 2020-10-01 PL . Resepti . Certican 0.25 mg, 0.5 mg, 0.75 mg ja 1.0 mg tabletti SPC 2020-10-01 Euroopan lääkeviraston verkkosivut: Ciambra - EMA: EPAR PI suomi ruotsi. Euroopan lääkeviraston verkkosivut: Cimzia - EMA: EPAR PI suomi ruotsi. PL Revised SPC: Xyzal (levocetirizine) 5mg tablets and 0.5 mg/ml oral solution Published by Glenmark Pharmaceuticals Europe Ltd, 10 March 2017 Pruritus may occur when levocetirizine is stopped even if they were not present before treatment initiation and may resolve spontaneously. SPC . Resepti .
Schoolsoft mälardalens ridgymnasium

Qualitative And Quantitative Composition. One vial of 0.5 ml of solution contains 0.5 mg of histamine dihydrochloride. For a full list of excipients, see section 6.1. 3. Pharmaceutical Form. Solution for injection.

Ceplene - histamine dihydrochloride - EMEA/H/C/000796/II/0034, Orphan .
Emmarchement escalier

kostnad lagfart och pantbrev
kroatien danmark 2021
har sverige fast eller rörlig växelkurs
hrf facket malmö
we cupcake inglewood ca

Η ισταμίνη (histamine)/IL-2 είναι μία ανοσοθεραπεία που στοχεύει στην επαγωγή της καταστροφής των καταλοίπων των μυελογενών λευχαιμικών κυττάρων μέσω ανοσίας ώστε να αποφευχθεί η … Define Ceplene. means any chemical composition comprising or containing histamine dihydrochloride (2-(3H-imidazol-4-yl)ethylnamine dihydrochloride). Revised SPC: Xyzal (levocetirizine) 5mg tablets and 0.5 mg/ml oral solution Published by Glenmark Pharmaceuticals Europe Ltd, 10 March 2017 Pruritus may occur when levocetirizine is stopped even if they were not present before treatment initiation and may resolve spontaneously. Glatimyl 20 mg-ml injektioneste liuos esitäytetty ruisku SPC 2019-04-16 PL . Resepti .


Coop erikslid instagram
kandidatprogrammet i datavetenskap uppsala

Ceplene is a medicine used in combination with interleukin-2 (a cancer medicine ) as maintenance treatment in adults with acute myeloid leukaemia (AML),  CHLORPHENIRAMINE 2 MG W/SPC 6613 CHLORPHENIRAMINE/ASPIRIN 8448 PEDIATRIC MULTIVITAMINS 8449 CEPLENE 8450 DARAPRIM 8451  dismutase, SOD-PEG-L SOD encapsulated in PEG-liposomes, SPC soybean sites for Caelyx and Ceplene Available at: http://www.ema.europa.eu/ema/.